期刊文献+

鹿瓜多肽对去卵巢大鼠骨密度及松质骨中TGF-β_1表达的影响 被引量:2

Influence of cervus and cucumis polypeptide injection on expression of TGF-β_1 in cancellated bone and bone mineral density in ovariectomized rats
暂未订购
导出
摘要 目的:鹿瓜多肽对去卵巢大鼠骨密度及松质骨中TGF-β1表达的影响。方法:将30只雌性SD大鼠,随机分为假手术(SHAM)组、去势(OVX)组、去势+鹿瓜多肽(OVX+CCP)组。术后20周测各组大鼠骨密度(BMD),利用免疫组织化学法观察各组大鼠松质骨中TGF-β1表达。结果:①OVX组与SHAM组相比较,松质骨中TGF-β1阳性细胞灰度值升高(P<0.05),CCP治疗组较OVX组灰度值降低(P<0.05);②与SHAM组相比,OVX组BMD明显降低(P<0.01);CCP治疗组各部位BMD高于去势组(P<0.05);结论:鹿瓜多肽注射液可以增加去势大鼠松质骨中TGF-β1的表达,抑制和延缓骨质疏松的形成,对雌激素缺乏引起的骨质疏松有预防作用。 Objective:To discuss the influence of cervus and cucumis polypeptide (CCP) on the expression of TGF - β1 in cancellated bone and bone mineral density (BMD) in ovariectomized rats. Methods:Thirty female SD rats were divided into three groups:sham operation (SHAM)group, ovariectomized (OVX)group and therapeutic (OVX + CCP )group. Bilateral ovariectomies were performed in OVX group and OVX + CCP group. The ovariectomized rats in OVX + CCP group were treated with CCP injection 1 day after operation. Twenty weeks after operation, the BMD of three groups was measured, and SABC immunohistochemistry was used to detect the expression of TGF - β1 in vertebrae bone. Results:The grayscale of cancellated bone in OVX group was significantly higher than that in SHAM group and OVX + CCP group ( P 〈 0.05 ). Compared with SHAM group, the BMD in OVX group was decreased significantly(P 〈0.01), and the BMD in OVX + CCP group was markedly higher than that in OVX group (P 〈 0.05 ). Conclusion: The CCP could increase the expression of TGF - β1 in cancellated bone of ovariectomized rats and inhibit the occurrence of osteoporosis in ovariectomized rats.
出处 《西北国防医学杂志》 CAS 2008年第1期28-30,共3页 Medical Journal of National Defending Forces in Northwest China
关键词 骨质疏松 鹿瓜多肽 骨矿物质密度 转化生长因子-Β1 Osteoporosis Cervus and cucumis polypeptide Bone mineral density Transforming growth factor - β1
  • 相关文献

参考文献8

二级参考文献25

  • 1刘国辉,张玉,杨述华.鹿瓜多肽临床应用的疗效观察及分析[J].中国医院药学杂志,2004,24(8):490-491. 被引量:41
  • 2赵广跃,朱庆生,吕宏升.鹿瓜多肽注射液治疗四肢骨干骨折的临床观察[J].中国骨与关节损伤杂志,2005,20(8):537-538. 被引量:32
  • 3Cheifetz S,Connect Tissue Res,1996年,35卷,1~4期,71页
  • 4郭世跋 罗先正 邱贵兴.骨质疏松基础与临床[M].天津:天津科学技术出版社,2001.181-189,347-348.
  • 5国家中医药管理局.中华人民共和国中医药行业标准(中医病症诊断疗效标准)[M].南京:南京大学出版社,1994.168.
  • 6Urist MR, Kovacs S, Yate KA. Regeneration of an enchondroma defect under the influence of an implant of human bone morphogenic protein. J Hand Surg (Am), 1986, 111:417.
  • 7Brueca B, Neumann CM. Bone pain. American Society Of Clinical Oncology, 1999, 393.
  • 8Onishi T,Ishidou Y,Nagamine T,et al.Distinct and overlapping patterns of localization of bone morphogenetic protein family members and a BMP typeⅡ receptor during fracture healing in rats.Bone,1998,22:605~612.
  • 9Sailer HF,Kolb E.Application of purified bone morphogenetic protein(BMP) in cranio-maxillo-facial surgery,BMP incompr-onised surgical reconstruction using titanium implant.J Cran-iomuxillofac Sug,1994,22(1):2.
  • 10刘忠厚.骨质疏松学.北京:北京科学出版社,1998,121-139.

共引文献163

同被引文献36

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部